Neuroendoscopy group (n = 28) | Non-neuroendoscopy group (n = 39) | P-value | |
---|---|---|---|
Duration of follow-up (year)1 | 2 (2, 4) | 2 (2, 3) | 0.330 |
Alleviation of symptoms, n (%)2 | <0.001* | ||
No effect | 2 (7.1) | 13 (33.3) | |
Improvement | 8 (28.6) | 24 (61.5) | |
Marked improvement | 18 (64.3) | 2 (5.1) | |
Total effective resection rate, n (%)2 | 26 (92.9) | 26 (66.7) | 0.011* |
Blood loss (ml)1 | 50 (50, 100) | 200 (200, 300) | <0.001* |
Hospitalization (day)1 | 10 (12, 15) | 10 (10, 40) | 0.596 |
Operative time (hour)1 | 2 (3, 3) | 4 (4, 5) | <0.001* |
Complication, n (%)2 | |||
Fever | 28 (100) | 0 (0.0) | <0.001* |
Subdural fluid | 8 (28.6) | 0 (0.0) | <0.001* |
Subcutaneous fluid | 4 (14.3) | 1 (2.6) | 0.152 |
Hydrocephalus | 0 (0.0) | 7 (17.9) | 0.036* |
Infection | 0 (0.0) | 1 (2.6) | 1.000 |
Intraventricular hemorrhage | 0 (0.0) | 3 (5.8) | 0.506 |
Recurrence | 0 (0.0) | 8 (20.5) | 0.017* |